Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Seneca

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Synapse (New York, N.Y.)|July 25, 2008
Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPANicholas Seneca, Sami S Zoghbi, Mette Skinbjerg, et al.
Nuclear Medicine and Biology|May 10, 2005
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkeySjoerd J Finnema, Nicholas Seneca, Lars Farde, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamideWilliam C Kreisl, Jeih-San Liow, Nobuyo Kimura, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2004
Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPETMasahiro Fujita, Andrea Varrone, Kyeong Min Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeysJeih-San Liow, William Kreisl, Sami S Zoghbi, et al.
Journal of Medicinal Chemistry|September 12, 2008
Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp functionNeva Lazarova, Sami S Zoghbi, Jinsoo Hong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoproteinNicholas Seneca, Sami S Zoghbi, Jeih-San Liow, et al.
Psychopharmacology|June 1, 2011
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyNicholas Seneca, Sjoerd J Finnema, István Laszlovszky, et al.
Neuroimage|January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse modelMette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Nuclear Medicine Communications|July 8, 2005
Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primatesNicholas Seneca, Bengt Andree, Nils Sjoholm, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Synapse (New York, N.Y.)|July 25, 2008
Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPANicholas Seneca, Sami S Zoghbi, Mette Skinbjerg, et al.
Nuclear Medicine and Biology|May 10, 2005
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkeySjoerd J Finnema, Nicholas Seneca, Lars Farde, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamideWilliam C Kreisl, Jeih-San Liow, Nobuyo Kimura, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2004
Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPETMasahiro Fujita, Andrea Varrone, Kyeong Min Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeysJeih-San Liow, William Kreisl, Sami S Zoghbi, et al.
Journal of Medicinal Chemistry|September 12, 2008
Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp functionNeva Lazarova, Sami S Zoghbi, Jinsoo Hong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoproteinNicholas Seneca, Sami S Zoghbi, Jeih-San Liow, et al.
Psychopharmacology|June 1, 2011
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyNicholas Seneca, Sjoerd J Finnema, István Laszlovszky, et al.
Neuroimage|January 26, 2010
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse modelMette Skinbjerg, Jeih-San Liow, Nicholas Seneca, et al.
Nuclear Medicine Communications|July 8, 2005
Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primatesNicholas Seneca, Bengt Andree, Nils Sjoholm, et al.
Pageof 4